An observational study in Covid19, sponsored by Gazi University. Completed at 1 site in Turkey. Open to female participants aged 15 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-04-01.
Sponsored by Gazi University · Observational
In literature, there is no data evaluating respiratory functions in volleyball players during Covid-19 pandemic. The aim of this study is to evaluate and compared pulmonary functions, respiratory muscle strength, body compositions and performance situations perceptions in female volleyball players with Covid-19 and non-Covid-19.
7,641 studies on the registry are indexed under COVID-19; 487 are open to participants now.
This study's enrollment of 42 is below the median of 261 across 3,136 observational studies indexed under COVID-19.
Browse COVID-19 studies →Gazi University is the lead sponsor of 532 studies on the registry; 99 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Female volleyball players
Exclusion Criteria:
Female volleyball players with Covid-19
Other: Respiratory functions
Female volleyball players with non Covid-19
Other: Respiratory functions
Respiratory muscle strength, pulmonary functions and body composition were evaluated in volleyball players
Respiratory muscle strength
Maximal inspiratory and expiratory muscle strength will be evaluated using mouth pressure device.
Time frame: 10 minute
FEV1
Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. FEV1 will be evaluated. The percentage of predicted value \<70% will be expressed as abnormal.
Time frame: 5 minute
FVC
Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. FVC will be evaluated. The percentage of predicted value \<70% will be expressed as abnormal
Time frame: 5 minute
FEV1/FVC
Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. FEV1/FVC will be evaluated.
Time frame: 5 minute
PEF
Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. PEF will be evaluated. The percentage of predicted value \<70% will be expressed as abnormal.
Time frame: 5 minute
FEF2575
Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. FEF2575 will be evaluated. The percentage of predicted value \<50% will be expressed as abnormal.
Time frame: 5 minute
Fat mass
Fat mass will be evaluated using TANITA bioelectrical impedance analysis.
Time frame: 2 minute
Fat mass percent
Fat mass percent will be evaluated using TANITA bioelectrical impedance analysis.
Time frame: 2 minute
Fat-free mass
Fat-free mass will be evaluated using TANITA bioelectrical impedance analysis.
Time frame: 2 minute
Body mass index
Body mass index will be evaluated using TANITA bioelectrical impedance analysis.
Time frame: 2 minute
Predicted muscle mass
Predicted muscle mass will be evaluated using TANITA bioelectrical impedance analysis.
Time frame: 2 minute
Symptom severity perceptions
Symptom severity perceptions will be evaluated Numeric Rating Scale.The severity of symptoms perceptions related to Covid are scored 0-10 point. Higher scores indicate higher severity of symptoms.
Time frame: 1 minute
Performance situations perceptions
Performance situations perceptions will be evaluated Numeric Rating Scale. Performance situations perceptions of all players are also scored 0-10 point. Higher scores indicate greater performance.
Time frame: 1 minute
Plan to share: Yes
This study is completed, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Gazi University